131 related articles for article (PubMed ID: 31785054)
1. Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients.
Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2020 Apr; 42(4):608-624. PubMed ID: 31785054
[TBL] [Abstract][Full Text] [Related]
2. Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.
Smith WH; Luskin I; Resende Salgado L; Scarborough BM; Lin JY; Özbek U; Miles BA; Gupta V; Bakst RL
Oral Oncol; 2019 May; 92():1-5. PubMed ID: 31010616
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Predictors of Persistent Opioid Use in Survivors of Head and Neck Cancer Treated With Curative Radiation.
Ganju R; Neeranjun R; Morse R; Lominska C; TenNapel M; Chen AM
Am J Clin Oncol; 2022 Apr; 45(4):161-167. PubMed ID: 35131971
[TBL] [Abstract][Full Text] [Related]
4. Opioid use patterns in patients with head and neck cancer receiving radiation therapy: Single-institution retrospective analysis characterizing patients who did not require opioid therapy.
Rich BJ; Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2021 Oct; 43(10):2973-2984. PubMed ID: 34143542
[TBL] [Abstract][Full Text] [Related]
5. Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.
Kwon JH; Hui D; Chisholm G; Bruera E
Oncologist; 2013 Jun; 18(6):768-74. PubMed ID: 23723332
[TBL] [Abstract][Full Text] [Related]
6. Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy.
Zhao L; Moon DH; Avkshtol V; Siropaides CH; Terauchi S; Day AT; Sumer BD; Hughes R; Sher DJ
Support Care Cancer; 2022 Sep; 30(9):7517-7525. PubMed ID: 35666302
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Opioid Use in Post-Surgical Management of Patients With Head and Neck Cancer.
Wang JJ; Rubin SJ; Devaiah AK; Faden DL; Salama AR; Edwards HA
Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):844-850. PubMed ID: 34521247
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
Gilley DR; Clark AD; Wieser ME; Bollig CA; Dooley LM; Biedermann GB
Head Neck; 2022 Jun; 44(6):1368-1376. PubMed ID: 35315549
[TBL] [Abstract][Full Text] [Related]
9. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study.
Papadomanolakis-Pakis N; Moore KM; Peng Y; Gomes T
Drug Alcohol Depend; 2021 Apr; 221():108601. PubMed ID: 33618194
[TBL] [Abstract][Full Text] [Related]
11. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
[TBL] [Abstract][Full Text] [Related]
12. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer.
Nugent SM; Slatore CG; Winchell K; Handley R; Clayburgh D; Chandra R; Hooker ER; Knight SJ; Morasco BJ
Head Neck; 2023 Aug; 45(8):2058-2067. PubMed ID: 37366072
[TBL] [Abstract][Full Text] [Related]
14. Long-term opioid therapy for chronic non-cancer pain in Germany.
Marschall U; L'hoest H; Radbruch L; Häuser W
Eur J Pain; 2016 May; 20(5):767-76. PubMed ID: 26492066
[TBL] [Abstract][Full Text] [Related]
15. Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study.
Deyo RA; Hallvik SE; Hildebran C; Marino M; Dexter E; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM
J Gen Intern Med; 2017 Jan; 32(1):21-27. PubMed ID: 27484682
[TBL] [Abstract][Full Text] [Related]
16. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
17. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
[TBL] [Abstract][Full Text] [Related]
18. Association between long-term NSAID use and opioid abuse among patients with breast cancer.
Onyeakusi NE; Gbadamosi SO; Mukhtar F; Orji C; Ugwuowo U; Igbeta O; Adejumo A; Akanbi O; Olufajo OA
Cancer Treat Res Commun; 2019; 21():100156. PubMed ID: 31306996
[TBL] [Abstract][Full Text] [Related]
19. Opioid use by patients in an orthopedics spine clinic.
Mahowald ML; Singh JA; Majeski P
Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
[TBL] [Abstract][Full Text] [Related]
20. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
